Virtus Advisers LLC Acquires Shares of 6,718 Merit Medical Systems, Inc. $MMSI

Posted by George Bondi on Aug 21st, 2026

Virtus Advisers LLC bought a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 6,718 shares of the medical instruments supplier’s stock, valued at approximately $466,000.

Several other large investors have also made changes to their positions in MMSI. Los Angeles Capital Management LLC bought a new position in Merit Medical Systems during the 4th quarter valued at about $25,000. Kilter Group LLC acquired a new position in Merit Medical Systems in the second quarter valued at about $25,000. Torren Management LLC bought a new stake in Merit Medical Systems during the fourth quarter worth about $38,000. Covestor Ltd grew its stake in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 336 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Merit Medical Systems during the third quarter worth approximately $42,000. Institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on MMSI. Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Bank of America increased their price target on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Canaccord Genuity Group raised their price target on Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a report on Friday, July 31st. Barrington Research set a $114.00 price objective on Merit Medical Systems in a research report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a research note on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $100.00.

Check Out Our Latest Stock Report on MMSI

Merit Medical Systems Trading Down 1.9%

Shares of NASDAQ MMSI opened at $90.27 on Friday. Merit Medical Systems, Inc. has a 1-year low of $59.74 and a 1-year high of $94.75. The company has a 50-day moving average of $76.93 and a two-hundred day moving average of $72.44. The company has a market cap of $5.39 billion, a PE ratio of 37.30, a P/E/G ratio of 2.31 and a beta of 0.49. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. Merit Medical Systems’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts expect that Merit Medical Systems, Inc. will post 3.81 earnings per share for the current fiscal year.

Merit Medical Systems Profile

(Free Report)

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.